An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
N Engl J Med
; 381(7): 603-613, 2019 08 15.
Article
in En
| MEDLINE
| ID: mdl-31180194
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
CD3 Complex
/
Diabetes Mellitus, Type 1
/
Antibodies, Monoclonal, Humanized
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
N Engl J Med
Year:
2019
Document type:
Article
Country of publication:
Estados Unidos